Cited by 63TGF-β signaling in diseasesGenetic factors in colorectal cancerGut microbiota and health

Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis

Open access
Gu, Shoujun, Zaidi, Sobia, Hassan, Md Imtaiyaz, Mohammad, Taj, Malta, Tathiane M., Noushmehr, Houtan, Nguyen, Bryan, Crandall, Keith A. +11 more·2020·Gastroenterology

Abstract

Background & aims We studied interactions among proteins of the carcinoembryonic antigen-related cell adhesion molecule (CEACAM) family, which interact with microbes, and transforming growth factor beta (TGFB) signaling pathway, which is often altered in colorectal cancer cells. We investigated mechanisms by which CEACAM proteins inhibit TGFB signaling and alter the intestinal microbiome to promote colorectal carcinogenesis.Methods We collected data on DNA sequences, messenger RNA expression levels, and patient survival times from 456 colorectal adenocarcinoma cases, and a separate set of 594 samples of colorectal adenocarcinomas, in The Cancer Genome Atlas. We performed shotgun metagenomic sequencing analyses of feces from wild-type mice and mice with defects in TGFB signaling (Sptbn1+/- and Smad4+/-/Sptbn1+/-) to identify changes in microbiota composition before development of colon tumors. CEACAM protein and its mutants were overexpressed in SW480 and HCT116 colorectal cancer cell lines, which were analyzed by immunoblotting and proliferation and colony formation assays.Results In colorectal adenocarcinomas, high expression levels of genes encoding CEACAM proteins, especially CEACAM5, were associated with reduced survival times of patients. There was an inverse correlation between expression of CEACAM genes and expression of TGFB pathway genes (TGFBR1, TGFBR2, and SMAD3). In colorectal adenocarcinomas, we also found an inverse correlation between expression of genes in the TGFB signaling pathway and genes that regulate stem cell features of cells. We found mutations encoding L640I and A643T in the B3 domain of human CEACAM5 in colorectal adenocarcinomas; structural studies indicated that these mutations would alter the interaction between CEACAM5 and TGFBR1. Overexpression of these mutants in SW480 and HCT116 colorectal cancer cell lines increased their anchorage-independent growth and inhibited TGFB signaling to a greater extent than overexpression of wild-type CEACAM5, indicating that they are gain-of-function mutations. Compared with feces from wild-type mice, feces from mice with defects in TGFB signaling had increased abundance of bacterial species that have been associated with the development of colon tumors, including Clostridium septicum, and decreased amounts of beneficial bacteria, such as Bacteroides vulgatus and Parabacteroides distasonis.Conclusion We found expression of CEACAMs and genes that regulate stem cell features of cells to be increased in colorectal adenocarcinomas and inversely correlated with expression of TGFB pathway genes. We found colorectal adenocarcinomas to express mutant forms of CEACAM5 that inhibit TGFB signaling and increase proliferation and colony formation. We propose that CEACAM proteins disrupt TGFB signaling, which alters the composition of the intestinal microbiome to promote colorectal carcinogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2019.09.023

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 57 · Cited by 63

Authors
Gu, S., Zaidi, S., Hassan, M. I., Mohammad, T., Malta, T. M., Noushmehr, H., Nguyen, B., Crandall, K. A., Srivastav, J., Obias, V., Lin, P., Nguyen, B.-N., Yao, M., Yao, R., King, C. H., Mazumder, R., Mishra, B., Rao, S., & Mishra, L.
Affiliations
  • George Washington University (US)
  • Jamia Millia Islamia (IN)
  • Henry Ford Health (US)
  • University of Toledo (US)
  • United States Department of Veterans Affairs (US)
Corresponding author
Mishra, Lopa
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2020-01
Volume
158
Issue
1
Pages
238-252
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2977665123
Cited by
63
References
57
Citations by year
2026: 1 · 2025: 7 · 2024: 15 · 2023: 12 · 2022: 11 · 2021: 12 · 2020: 5
FWCI
2.40
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health (R01 AA023146, R01 CA236591, U01 CA230690, I01BX003732)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
CEACAM5, CEACAM, TGF-beta signaling, colorectal carcinogenesis, colorectal adenocarcinoma, gut microbiota, TGFBR1, Smad3, gain-of-function mutations, B3 domain, Clostridium septicum, Bacteroides vulgatus, Parabacteroides distasonis, cancer stemness, cell proliferation, patient survival, host-microbe interactions
MeSH terms
Gastrointestinal Microbiome, Protein Domains, Gain of Function Mutation, Receptor, Transforming Growth Factor-beta Type I, Animals, Bacteria, Carcinoembryonic Antigen, Disease Models, Animal, Feces, Humans, Mice, Transgenic, Colorectal Neoplasms, Signal Transduction, Gene Expression Regulation, Neoplastic, Survival Analysis, Transforming Growth Factor beta, Spheroids, Cellular, HCT116 Cells, Mice, Smad4 Protein, Metagenomics, GPI-Linked Proteins, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review